EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Synthesis, Characterization, In Vitro and In Silico Investigation of Azo‐Based Co(III), Zn(II), and Pd(II) Complexes Against Human Leukemia

Yareeb J Sahar iD, Abbas F Yasir iD, Hussein A K Kyhoiesh iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Yareeb J Sahar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, University of Al-Qadisiyah, Diwaniya, Iraq. Hauptthemen laut MEDLINE: Antineoplastic Agents, Azo Compounds, Coordination Complexes, Leukemia. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The new azo ligand (E)‐2‐((1 H ‐indol‐3‐yl)diazenyl)benzoic acid (IDB) was synthesized and complexes of Co(III), Zn(II), and Pd(II) were prepared. Elemental analysis, FT‑IR, 1 H‑NMR, 1 3 C‑NMR, UV–vis, mass spectrometry, molar conductivity, magnetic susceptibility, XRD and FE‐SEM were used to fully characterize the compounds. The spectroscopic data are consistent with the Co(III) and Zn(II) being coordinated as bidentate N,O‐donors, with the azo nitrogen and deprotonated carboxylate oxygen, and with the Pd(II) being square‐planar. The Pd(II) complex demonstrated cytotoxic activity against HL‑60 cells (IC 50 = 134.4 µg/mL) with modest selectivity over normal HdFn fibroblasts (IC 50 = 164.7 µg/mL, selectivity index = 1.23) among the tested complexes. Mechanistically, it significantly decreased malondialdehyde (MDA) levels in both cancer and normal cells, suggesting modulation of oxidative stress. The Pd(II) complex showed high binding affinity with Aurora kinase (Abl T315I mutant, PDB: 2V7A) with hydrogen bond with ASP 381 and ASN 322 and π–H interaction with LEU 248. The complexes are predicted to have reduced oral bioavailability, but are still good candidates for parenteral use, while the ligand is predicted to have good drug‑like properties. Overall, these results indicate that the Pd(II) complex is a promising lead compound for targeted leukemia therapy, but additional in vivo testing is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAzo CompoundsCoordination ComplexesLeukemiaHumansZincPalladiumCobaltDrug Screening Assays, AntitumorHL-60 CellsMolecular StructureCell ProliferationStructure-Activity RelationshipMolecular Docking Simulation

Stichwörter der Autor:innen

2‐aminobenzoic acidADMETIndoleMTTMetal complexes

Substanzen

Antineoplastic AgentsZincAzo CompoundsCoordination ComplexesPalladiumCobalt

Autor:innen und Institutionen

  • Department of Chemistry, College of Science, University of Al-Qadisiyah, Diwaniya, Iraq.
  • Department of Chemistry, Education General Directorate in Al-Muthanna, Samawah, Iraq.
  • Department of Chemistry, College of Science, National University of Science and Technology, Nasiriyah, Dhi Qar, Iraq.

ORCID-Profile: Yareeb J Sahar, Abbas F Yasir, Hussein A K Kyhoiesh

Zitieren

APA

Sahar, Y. J., Yasir, A. F., & Kyhoiesh, H. A. K. (2026). Synthesis, Characterization, In Vitro and In Silico Investigation of Azo‐Based Co(III), Zn(II), and Pd(II) Complexes Against Human Leukemia. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71775

Vancouver

Sahar YJ, Yasir AF, Kyhoiesh HAK. Synthesis, Characterization, In Vitro and In Silico Investigation of Azo‐Based Co(III), Zn(II), and Pd(II) Complexes Against Human Leukemia. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71775

BibTeX
@article{Sahar2026,
  author = {Sahar, Yareeb J and Yasir, Abbas F and Kyhoiesh, Hussein A K},
  title = {Synthesis, Characterization, In Vitro and In Silico Investigation of Azo‐Based Co(III), Zn(II), and Pd(II) Complexes Against Human Leukemia},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71775}
}
Kostenlos starten →